Menu

Violetta ZUJOVIC

PARIS 13

En résumé

After building an extensive knowledge in Neuroscience and Pharmacology fields, I have now a permanent position as a principal investigator at the "Institut du cerveau et de la moelle épinière". My interest are oriented toward the search of new drug targets and therapeutic strategies for central nervous system (CNS) disorders.

During my PhD and postdoctoral training, I acquired both in vivo and in vitro expertise in studies of CNS pathology. As a graduate student, I developed different models of cerebral inflammation in order to test potential drugs; notably diverse co-culture systems studying the interaction between immune cells and neurons. Along my training, I mastered a wide variety of surgical techniques and animal behavior evaluation. I assessed different brain and spinal cord injuries models. Analysis of the effect of treatments was performed using various tools: locomotor evaluation, molecular biology (microarrays, in situ hybridization), biochemistry (western blot, ELISA) and immunohistological analysis.

Since 2006, I am the project leader of a team composed of 1 engineer, 2 technicians and 2 students; collaborating with various national and international teams. Our efforts resulted in 10 original publications and 6 invitations to international conferences.

Mes compétences :
English
FLUENT
French
Pharmacology
Stem Cells
USA
R&D
Gestion de projet
Communication

Entreprises

  • INSERM - Chercheur

    PARIS 13 2004 - maintenant Immune cell role in central nervous system repair : molecular and cellular analysis. (8 original publications, 5 review papers, 10 invitation to international congress)
  • Pharmacology department, University of Florida - Post doctoral associate

    2001 - 2004 - Development of chemokine antagonist using a viral protein vMIP II (1 paper 2nd author)
    - Identification of new genes implicated in peripheral nervous system regeneration.(1 publication 1st author)
  • Sanofi-Synthelabo - PhD student in the central nervous system department

    Paris 1998 - 2001 Study of role of Fractalkine in the development of inflammation in the central nervous system. (3 original publications 1st author)

Formations

Pas de formation renseignée

Réseau

Annuaire des membres :